Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-06 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-06 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-05 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |